1. Loxham M, Nieuwenhuijsen MJ. Health effects of particulate matter air pollution in underground railway systems - a critical review of the evidence. Part Fibre Toxicol. 2019; 16:12. PMID:
30841934.
Article
2. Almetwally AA, Bin-Jumah M, Allam AA. Ambient air pollution and its influence on human health and welfare: an overview. Environ Sci Pollut Res Int. 2020; 27:24815–24830. PMID:
32363462.
Article
3. Lynch HN, Loftus CT, Cohen JM, Kerper LE, Kennedy EM, Goodman JE. Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer. Regul Toxicol Pharmacol. 2016; 82:53–93. PMID:
27765718.
Article
4. Wu JZ, Ge DD, Zhou LF, Hou LY, Zhou Y, Li QY. Effects of particulate matter on allergic respiratory diseases. Chronic Dis Transl Med. 2018; 4:95–102. PMID:
29988900.
Article
5. Combes A, Franchineau G. Fine particle environmental pollution and cardiovascular diseases. Metabolism. 2019; 100S:153944. PMID:
31610849.
Article
6. Liu B, Wu J, Zhang J, Wang L, Yang J, Liang D, Dai Q, Bi X, Feng Y, Zhang Y, Zhang Q. Characterization and source apportionment of PM
2.5 based on error estimation from EPA PMF 5.0 model at a medium city in China. Environ Pollut. 2017; 222:10–22. PMID:
28088626.
7. Yang Y, Ruan Z, Wang X, Yang Y, Mason TG, Lin H, Tian L. Short-term and long-term exposures to fine particulate matter constituents and health: a systematic review and meta-analysis. Environ Pollut. 2019; 247:874–882. PMID:
30731313.
Article
8. He M, Ichinose T, Yoshida S, Ito T, He C, Yoshida Y, Arashidani K, Takano H, Sun G, Shibamoto T. PM2.5-induced lung inflammation in mice: differences of inflammatory response in macrophages and type II alveolar cells. J Appl Toxicol. 2017; 37:1203–1218. PMID:
28555929.
Article
9. Tang Q, Huang K, Liu J, Wu S, Shen D, Dai P, Li C. Fine particulate matter from pig house induced immune response by activating TLR4/MAPK/NF-κB pathway and NLRP3 inflammasome in alveolar macrophages. Chemosphere. 2019; 236:124373. PMID:
31336238.
Article
10. Shukla A, Timblin C, BeruBe K, Gordon T, McKinney W, Driscoll K, Vacek P, Mossman BT. Inhaled particulate matter causes expression of nuclear factor (NF)-kappaB-related genes and oxidant-dependent NF-kappaB activation
in vitro
. Am J Respir Cell Mol Biol. 2000; 23:182–187. PMID:
10919984.
11. Jeong S, Park SA, Park I, Kim P, Cho NH, Hyun JW, Hyun YM. PM2.5 Exposure in the respiratory system induces distinct inflammatory signaling in the lung and the liver of mice. J Immunol Res. 2019; 2019:3486841. PMID:
31871955.
Article
12. Wyatt LH, Devlin RB, Rappold AG, Case MW, Diaz-Sanchez D. Low levels of fine particulate matter increase vascular damage and reduce pulmonary function in young healthy adults. Part Fibre Toxicol. 2020; 17:58. PMID:
33198760.
Article
13. Piao MJ, Ahn MJ, Kang KA, Ryu YS, Hyun YJ, Shilnikova K, Zhen AX, Jeong JW, Choi YH, Kang HK, Koh YS, Hyun JW. Particulate matter 2.5 damages skin cells by inducing oxidative stress, subcellular organelle dysfunction, and apoptosis. Arch Toxicol. 2018; 92:2077–2091. PMID:
29582092.
Article
14. Lee H, Hwang-Bo H, Ji SY, Kim MY, Kim SY, Park C, Hong SH, Kim GY, Song KS, Hyun JW, Choi YH. Diesel particulate matter2.5 promotes epithelial-mesenchymal transition of human retinal pigment epithelial cells via generation of reactive oxygen species. Environ Pollut. 2020; 262:114301. PMID:
32155554.
Article
15. Wei H, Yuan W, Yu H, Geng H. Cytotoxicity induced by fine particulate matter (PM2.5) via mitochondria-mediated apoptosis pathway in rat alveolar macrophages. Environ Sci Pollut Res Int. 2021; 21:1–11.
16. Rao X, Zhong J, Brook RD, Rajagopalan S. Effect of particulate matter air pollution on cardiovascular oxidative stress pathways. Antioxid Redox Signal. 2018; 28:797–818. PMID:
29084451.
Article
17. Øvrevik J. Oxidative potential versus biological effects: a review on the relevance of cell-free/abiotic assays as predictors of toxicity from airborne particulate matter. Int J Mol Sci. 2019; 20:4772.
Article
18. Guan L, Geng X, Stone C, Cosky EE, Ji Y, Du H, Zhang K, Sun Q, Ding Y. PM
2.5 exposure induces systemic inflammation and oxidative stress in an intracranial atherosclerosis rat model. Environ Toxicol. 2019; 34:530–538. PMID:
30672636.
19. Panossian A, Wikman G. Pharmacology of
Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. J Ethnopharmacol. 2008; 118:183–212. PMID:
18515024.
20. Zhang M, Xu L, Yang H.
Schisandra chinensis Fructus and its active ingredients as promising resources for the treatment of neurological diseases. Int J Mol Sci. 2018; 19:1970.
21. Chun JN, Cho M, So I, Jeon JH. The protective effects of
Schisandra chinensis fruit extract and its lignans against cardiovascular disease: a review of the molecular mechanisms. Fitoterapia. 2014; 97:224–233. PMID:
24976588.
22. Nowak A, Zakłos-Szyda M, Błasiak J, Nowak A, Zhang Z, Zhang B. Potential of Schisandra chinensis (Turcz.) Baill. in human health and nutrition: a review of current knowledge and therapeutic perspectives. Nutrients. 2019; 11:333.
23. Song FJ, Zeng KW, Chen JF, Li Y, Song XM, Tu PF, Wang XM. Extract of Fructus
Schisandrae chinensis inhibits neuroinflammation mediator production from microglia
via NF-kappa B and MAPK pathways. Chin J Integr Med. 2019; 25:131–138. PMID:
29790065.
24. Jeong JW, Lee HH, Choi EO, Lee KW, Kim KY, Kim SG, Hong SH, Kim GY, Park C, Kim HK, Choi YW, Choi YH. Schisandrae Fructus inhibits IL-1beta-induced matrix metalloproteinases and inflammatory mediators production in SW1353 human chondrocytes by suppressing NF-kappaB and MAPK activation. Drug Dev Res. 2015; 76:474–483. PMID:
26443270.
25. Dilshara MG, Jayasooriya RG, Kang CH, Lee S, Park SR, Jeong JW, Choi YH, Seo YT, Jang YP, Kim GY. Downregulation of pro-inflammatory mediators by a water extract of
Schisandra chinensis (Turcz.) Baill fruit in lipopolysaccharide-stimulated RAW 264.7 macrophage cells. Environ Toxicol Pharmacol. 2013; 36:256–264. PMID:
23686005.
26. Kang JS, Han MH, Kim GY, Kim CM, Kim BW, Hwang HJ, Hyun Y. Nrf2-mediated HO-1 induction contributes to antioxidant capacity of a Schisandrae Fructus ethanol extract in C2C12 myoblasts. Nutrients. 2014; 6:5667–5678. PMID:
25493944.
27. Karna KK, Choi BR, Kim MJ, Kim HK, Park JK. The effect of Schisandra chinensis Baillon on cross-talk between oxidative stress, endoplasmic reticulum stress, and mitochondrial signaling pathway in testes of varicocele-induced SD rat. Int J Mol Sci. 2019; 20:5785.
28. Jeong JW, Kim J, Choi EO, Kwon DH, Kong GM, Choi IW, Kim BH, Kim GY, Lee KW, Kim KY, Kim SG, Choi YW, Hong SH, Park C, Choi YH. Schisandrae Fructus ethanol extract ameliorates inflammatory responses and articular cartilage damage in monosodium iodoacetate-induced osteoarthritis in rats. EXCLI J. 2017; 16:265–277. PMID:
28507472.
29. Choi YH. Trans-cinnamaldehyde protects C2C12 myoblasts from DNA damage, mitochondrial dysfunction and apoptosis caused by oxidative stress through inhibiting ROS production. Genes Genomics. 2021; 43:303–312. PMID:
32851512.
Article
30. Chae BS. Effect of low-dose corticosterone pretreatment on the production of inflammatory mediators in super-low-dose LPS-primed immune cells. Toxicol Res. 2021; 37:47–57. PMID:
33489857.
Article
31. Park S, Kim M, Hong Y, Lee H, Tran Q, Kim C, Kwon SH, Park J, Park J, Kim SH. Myristoylated TMEM39AS41, a cell-permeable peptide, causes lung cancer cell death. Toxicol Res. 2020; 36:123–130. PMID:
32257924.
Article
32. Park JW, Lee SJ, Kim JE, Kang MJ, Bae SJ, Choi YJ, Gong JE, Kim KS, Jung YS, Cho JY, Choi YS, Hwang DY, Song HK. Comparison of response to LPS-induced sepsis in three DBA/2 stocks derived from different sources. Lab Anim Res. 2021; 37:2. PMID:
33407886.
Article
33. Hwangbo H, Kim SY, Lee H, Park SH, Hong SH, Park C, Kim GY, Leem SH, Hyun JW, Cheong J, Choi YH. Auranofin enhances sulforaphane-mediated apoptosis in hepatocellular carcinoma Hep3B cells through inactivation of the PI3K/Akt signaling pathway. Biomol Ther. 2020; 28:443–455.
Article
34. Jeong JW, Cha HJ, Han MH, Hwang SJ, Lee DS, Yoo JS, Choi IW, Kim S, Kim HS, Kim GY, Hong SH, Park C, Lee HJ, Choi YH. Spermidine protects against oxidative stress in inflammation models using macrophages and zebrafish. Biomol Ther. 2018; 26:146–156.
Article
35. Soufli I, Toumi R, Rafa H, Touil-Boukoffa C. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther. 2016; 7:353–360. PMID:
27602236.
Article
36. Aleem D, Tohid H. Pro-inflammatory cytokines, biomarkers, genetics and the immune system: a mechanistic approach of depression and psoriasis. Rev Colomb Psiquiatr. 2018; 47:177–186.
Article
37. Saini R, Singh S. Inducible nitric oxide synthase: an asset to neutrophils. J Leukoc Biol. 2019; 105:49–61. PMID:
30285282.
Article
38. Yao C, Narumiya S. Prostaglandin-cytokine crosstalk in chronic inflammation. Br J Pharmacol. 2019; 176:337–354. PMID:
30381825.
Article
39. Wang T, He C, Yu X. Pro-inflammatory cytokines: new potential therapeutic targets for obesity-related bone disorders. Curr Drug Targets. 2017; 18:1664–1675. PMID:
28056748.
Article
40. Hu F, Lou N, Jiao J, Guo F, Xiang H, Shang D. Macrophages in pancreatitis: Mechanisms and therapeutic potential. Biomed Pharmacother. 2020; 131:110693. PMID:
32882586.
Article
41. Zhang H, Cai D, Bai X. Macrophages regulate the progression of osteoarthritis. Osteoarthritis Cartilage. 2020; 28:555–561. PMID:
31982565.
Article
42. Jalava PI, Salonen RO, Pennanen AS, Happo MS, Penttinen P, Hälinen AI, Sillanpää M, Hillamo R, Hirvonen MR. Effects of solubility of urban air fine and coarse particles on cytotoxic and inflammatory responses in RAW 264.7 macrophage cell line. Toxicol Appl Pharmacol. 2008; 229:146–160. PMID:
18325559.
Article
43. Bekki K, Ito T, Yoshida Y, He C, Arashidani K, He M, Sun G, Zeng Y, Sone H, Kunugita N, Ichinose T. PM2.5 collected in China causes inflammatory and oxidative stress responses in macrophages through the multiple pathways. Environ Toxicol Pharmacol. 2016; 45:362–369. PMID:
27393915.
44. Zhu J, Zhao Y, Gao Y, Li C, Zhou L, Qi W, Zhang Y, Ye L. Effects of different components of PM2.5 on the expression levels of NF-kappaB family gene mRNA and inflammatory molecules in human macrophage. Int J Environ Res Public Health. 2019; 16:1408.
45. Yin J, Xia W, Li Y, Guo C, Zhang Y, Huang S, Jia Z, Zhang A. COX-2 mediates PM2.5-induced apoptosis and inflammation in vascular endothelial cells. Am J Transl Res. 2017; 9:3967–3976. PMID:
28979673.
46. Beck-Speier I, Kreyling WG, Maier KL, Dayal N, Schladweiler MC, Mayer P, Semmler-Behnke M, Kodavanti UP. Soluble iron modulates iron oxide particle-induced inflammatory responses
via prostaglandin E
2 synthesis:
in vitro and
in vivo studies. Part Fibre Toxicol. 2009; 6:34. PMID:
20028532.
Article
47. Migliaccio CT, Kobos E, King QO, Porter V, Jessop F, Ward T. Adverse effects of wood smoke PM
2.5 exposure on macrophage functions. Inhal Toxicol. 2013; 25:67–76. PMID:
23363038.
48. Li W, Cai ZN, Mehmood S, Liang LL, Liu Y, Zhang HY, Chen Y, Lu YM. Anti-inflammatory effects of
Morchella esculenta polysaccharide and its derivatives in fine particulate matter-treated NR8383 cells. Int J Biol Macromol. 2019; 129:904–915. PMID:
30776439.
49. Rigoglou S, Papavassiliou AG. The NF-κB signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 2013; 45:2580–2584. PMID:
24004831.
Article
50. Schuliga M. NF-kappaB signaling in chronic inflammatory airway disease. Biomolecules. 2015; 5:1266–1283. PMID:
26131974.
Article
51. Shi Y, Batibawa JW, Maiga M, Sun B, Li Y, Duan J, Sun Z. Identification and validation of metformin protects against PM
2.5-induced macrophages cytotoxicity by targeting toll like receptor pathway. Chemosphere. 2020; 251:126526. PMID:
32443237.
52. Liu Z, Ren Z, Zhang J, Chuang CC, Kandaswamy E, Zhou T, Zuo L. Role of ROS and nutritional antioxidants in human diseases. Front Physiol. 2018; 9:477. PMID:
29867535.
Article
53. Mills EL, O'Neill LA. Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur J Immunol. 2016; 46:13–21. PMID:
26643360.
Article
54. Bailone RL, Fukushima HC, Ventura Fernandes BH, De Aguiar LK, Corrêa T, Janke H, Grejo Setti P, Roça RO, Borra RC. Zebrafish as an alternative animal model in human and animal vaccination research. Lab Anim Res. 2020; 36:13. PMID:
32382525.
Article
55. Ren F, Huang Y, Tao Y, Ji C, Aniagu S, Jiang Y, Chen T. Resveratrol protects against PM2.5-induced heart defects in zebrafish embryos as an antioxidant rather than as an AHR antagonist. Toxicol Appl Pharmacol. 2020; 398:115029. PMID:
32376357.
Article
56. Zhang Y, Li S, Li J, Han L, He Q, Wang R, Wang X, Liu K. Developmental toxicity induced by PM2.5 through endoplasmic reticulum stress and autophagy pathway in zebrafish embryos. Chemosphere. 2018; 197:611–621. PMID:
29407824.
Article
57. Dai YL, Jiang YF, Lu YA, Yu JB, Kang MC, Jeon YJ. Fucoxanthin-rich fraction from
Sargassum fusiformis alleviates particulate matter-induced inflammation
in vitro and
in vivo
. Toxicol Rep. 2021; 8:349–358. PMID:
33665132.
58. de Abreu MS, Giacomini AC, Genario R, Dos Santos BE, da Rosa LG, Demin KA, Wappler-Guzzetta EA, Kalueff AV. Neuropharmacology, pharmacogenetics and pharmacogenomics of aggression: the zebrafish model. Pharmacol Res. 2019; 141:602–608. PMID:
30708051.
Article
59. Duan J, Yu Y, Li Y, Wang Y, Sun Z. Inflammatory response and blood hypercoagulable state induced by low level co-exposure with silica nanoparticles and benzo[a]pyrene in zebrafish (
Danio rerio) embryos. Chemosphere. 2016; 151:152–162. PMID:
26943738.